Ardent Health, Inc. (NYSE:ARDT – Get Free Report) has received an average rating of “Hold” from the thirteen research firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $14.25.
Several equities analysts have weighed in on ARDT shares. Bank of America dropped their price objective on Ardent Health from $12.00 to $10.00 and set an “underperform” rating for the company in a report on Thursday, November 13th. Guggenheim reduced their target price on Ardent Health from $18.00 to $15.00 and set a “buy” rating on the stock in a report on Tuesday, November 18th. Wall Street Zen cut Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, November 23rd. Stephens cut their price objective on shares of Ardent Health from $21.00 to $17.00 and set an “overweight” rating for the company in a research report on Friday, November 14th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Ardent Health in a research note on Monday, December 29th.
Check Out Our Latest Stock Analysis on Ardent Health
Institutional Trading of Ardent Health
Ardent Health Stock Performance
Shares of NYSE:ARDT opened at $9.20 on Tuesday. Ardent Health has a 12-month low of $8.07 and a 12-month high of $15.48. The company’s 50 day moving average price is $9.01 and its two-hundred day moving average price is $10.89. The firm has a market cap of $1.32 billion, a PE ratio of 9.58 and a beta of 0.46. The company has a quick ratio of 1.95, a current ratio of 2.08 and a debt-to-equity ratio of 0.67.
Ardent Health (NYSE:ARDT – Get Free Report) last released its quarterly earnings results on Wednesday, March 4th. The company reported $0.32 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.03). The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.63 billion. Ardent Health had a net margin of 2.15% and a return on equity of 14.46%. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Equities research analysts predict that Ardent Health will post 1.23 earnings per share for the current year.
About Ardent Health
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Read More
- Five stocks we like better than Ardent Health
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
